Pharmaceutical Preparations · DE · CIK 1377121
Develops targeted peptide therapeutics for inflammation, immunology, hematology, and metabolic diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 26, 2026: 6 sold $29.5M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Ali AsifChief Financial Officer | Sell | 24,765 | $104.24 | $2.6M |
| Mar 26, 2026 | Selick Harold EDirector | Sell | 24,000 | $105.00 | $2.5M |
| Mar 26, 2026 | Molina Arturo MdChief Medical Officer | Sell | 15,000 | $104.79 | $1.6M |
| Mar 25, 2026 | Patel Dinesh V Ph DPresident and CEO | Sell | 54,641 | $101.00 | $5.5M |
| Mar 24, 2026 | Patel Dinesh V Ph DPresident and CEO | Sell | 59 | $101.00 | $6K |
| Feb 17, 2026 | Williams Lewis TDirector | Sell | 18,000 | $82.42 | $1.5M |
| Feb 6, 2026 | Waddill William D.Director | Sell | 20,000 | $83.68 | $1.7M |
| Jan 27, 2026 | Ali AsifChief Financial Officer | Sell | 28,000 | $83.13 | $2.3M |
| Jan 27, 2026 | Ali AsifChief Financial Officer | Sell | 18,203 | $83.14 | $1.5M |
| Jan 27, 2026 | Molina Arturo MdChief Medical Officer | Sell | 5,000 | $82.00 | $410K |
| Jan 27, 2026 | Patel Dinesh V Ph DPresident and CEO | Sell | 4,068 | $83.19 | $338K |
| Jan 26, 2026 | Patel Dinesh V Ph DPresident and CEO | Sell | 14,205 | $84.05 | $1.2M |
| Jan 26, 2026 | Patel Dinesh V Ph DPresident and CEO | Sell | 10,685 | $84.00 | $898K |
| Jan 26, 2026 | Molina Arturo MdChief Medical Officer | Sell | 5,000 | $82.28 | $411K |
| Jan 23, 2026 | Patel Dinesh V Ph DPresident and CEO | Sell | 19,315 | $84.59 | $1.6M |
| Jan 23, 2026 | Molina Arturo MdChief Medical Officer | Sell | 13,151 | $82.42 | $1.1M |
| Jan 20, 2026 | Patel Dinesh V Ph DPresident and CEO | Sell | 34,438 | $82.48 | $2.8M |
| Jan 20, 2026 | Molina Arturo MdChief Medical Officer | Sell | 9,514 | $82.48 | $785K |
| Jan 20, 2026 | Ali AsifChief Financial Officer | Sell | 8,588 | $82.48 | $708K |
| Nov 17, 2025 | Molina Arturo MdChief Medical Officer | Sell | 2,712 | $84.77 | $230K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.